Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease

Krebs von den Lungen-6 (KL-6) levels measured at baseline have been reported as a circulating biomarker useful for the detection, evaluation of severity and assessment of risk of the progression of interstitial lung disease (ILD) in patients with systemic sclerosis (SSc). In this retrospective study...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirai, Yuichiro, Fukue, Ryosuke, Kaneko, Yuko, Kuwana, Masataka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619247/
https://www.ncbi.nlm.nih.gov/pubmed/34829353
http://dx.doi.org/10.3390/diagnostics11112007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619247/
https://www.ncbi.nlm.nih.gov/pubmed/34829353
http://dx.doi.org/10.3390/diagnostics11112007

Ejemplares similares